Stock Rich List
#5041 on the rich list of 14,644 insiders

David Y. Liu

Chief R&D Strategy Officer at Protagonist Therapeutics. Based in Newark, California.

$20.8M
in disclosed stock, −$526K (−2.47%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
5041st of 14,644
Companies held
1
Largest holding
PTGX, 100.0% of total
Latest SEC filing
Nov 16, 2022

What the $20.8M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Protagonist Therapeutics PTGX
Common Stock
Directly167,590$124.02$20.8M100.0%Form 4, Nov 16, 2022

Share counts are the amounts David Y. Liu reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
5038Jeffrey Hays Cox
President, IBEX Digital, IBEX. Washington, DC
$20.8M−$686K (−3.19%)
5039S. Matthew Schultz
CEO & Chairman, CleanSpark. Henderson, NV
$20.8M−$1.3M (−5.96%)
5040Daniel Robinson V. II
Director, NBT Bancorp. Norwich, NY
$20.8M−$397K (−1.87%)
5041David Y. Liu
Chief R&D Strategy Officer, Protagonist Therapeutics. Newark, CA
$20.8M−$526K (−2.47%)
5042Neil Ashe
President & CEO, Acuity. Atlanta, GA
$20.8M−$398K (−1.88%)
5043Doyle N. Beneby
Director, Quanta Services. Los Angeles, CA
$20.8M−$490K (−2.31%)
5044Bratin Saha
Chief Product & Tech Officer, DigitalOcean Holdings. Broomfield, CO
$20.8M−$951K (−4.38%)

Other Protagonist Therapeutics insiders

All PTGX insiders

Questions

How much stock does David Y. Liu own?

David Y. Liu holds $20,784,512 in listed stock based on SEC filings and current prices, mostly Protagonist Therapeutics (PTGX). That ranks 5041st on the Stock Rich List.

Is this David Y. Liu's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.